The programme of meetings at the British Pharmaceutical Conference is set out on this and the following two pages. Information on fringe conference sessions organised by other pharmacy bodies is included but, to keep the programme as simple as possible, details of the exhibition, science fair and the social activities have been omitted. Information about those activities can be found on p107.
|
|
| 10am: Opening address
Welcome and introduction by the President of the Royal Pharmaceutical Society (Mrs Christine Glover) |
2pm: Glaxo Wellcome international achievement award lecture
"Advances in drug delivery and tissue engineering" by Professor Bob Langer (Massachusetts Institute of Technology, United States) |
| 10.10am: Practice research award lecture
"The many faces of prescribing" by Miss Judy Cantrill (clinical senior lecturer, school of pharmacy and pharmaceutical sciences, University of Manchester) |
2.15pm: Pharmacists and pain control
Speaker: Professor Nicholas Moore (University of Bordeaux) |
| 10.10am: Young scientists symposium - Drug delivery in the future (Details to be announced) | 2.15pm: Community pharmacy and public health session
"The public health agenda" by Ms Yve Buckland (chairman, Health Development Agency); "Tackling teenage pregnancy" by Mrs Karen O'Brien (Trafford Emergency Contraception Project, Manchester health authority) |
| 11.30am: Community and primary care pharmacy session - Views on the community pharmacy strategy
"The general medical practitioner's view" by Professor Mike Pringle (chairman, Royal College of General Practitioners); "The pharmacist's view" by Mr Peter Curphey (member of the Royal Pharmaceutical Society's Council) |
2.15pm: Pharmacy practice research - Oral communications
Topic: "Community and primary care pharmacy" |
| 11.30pm: Hospital pharmacy session - Unified drugs budgets and the management of the introduction of expensive new drugs
Speakers: Mr Peter Sharott (regional pharmaceutical adviser, London, NHS Executive); and Miss Sonia Colwill (head of public health development, Lambeth, Southwark and Lewisham health authority) |
2.15pm: Hospital pharmacy session - The role of clinical technicians
Speaker: Ms Shirley North (chief technician, Guy's and St Thomas's hospital NHS trust) |
| 11.30am: Information technology session
Topics: "Networking", "E-commerce" and "Information for professionals and the public" |
2.15 pm: IT showcase |
| 1pm: Practice research poster sessions | 2.15pm: National Association of Women Pharmacists - Reflexology
Topics to include: "History of reflexology"; "Principles and effects"; Aims and benefits of treatment" and "Techniques and demonstrations" |
| 2pm: Glaxo Wellcome international achievement award lecture
"Advances in drug delivery and tissue engineering" by Professor Bob Langer (Massachusetts Institute of Technology, United States) |
3pm: Medicines for the new millennium
"Genes and cancer: hope or hype?" by Professor Gordon McVie (director general, Cancer Research Campaign; "Discovery of new drug molecules" by Professor Sir David Lane (University of Dundee); and "Link between imaging and medicines in the new millennium" by Dr John Padfield (chief executive, Imaging Nycomed Amersham) |
| 4pm: E-commerce: implications for supply, patient information and prescribing "E-commerce and the European Union" (speaker to be confirmed); "Threat or opportunity to pharmacy" (speaker to be confirmed); discussion, led by Mr Ian Shepherd (group head of information management and strategy, Royal Pharmaceutical Society) | |
| 5pm: Science poster sessions | |
| 5pm: Practice research poster session | |
| 5pm: Primary Care Pharmacists Association - "What can the PCPA offer the profession?" |
| 7.30am: Community Pharmacists Group breakfast session - "E-commerce: threat or opportunity for community pharmacy?" | 2.30pm: Community and primary care pharmacy session - Controlling the drug budget in primary care Speakers: Mr Alan Burns (chief executive, Cambridgeshire health authority), Dr Jim Smith (pharmaceutical adviser, Northern and Yorkshire regional office, NHS Executive) and Dr Chris James (chairman, Southampton Central primary care group) |
| 9am: Science Chairman's address
"From genomics to the clinic: The challenge for molecular science?" by Professor Martyn Davies (University of Nottingham) |
2.30pm: Pharmacy practice research - Poster discussion forum
Topics to include: "Pharmaceutical care"' "Antibiotic use in primary care" "Hospital pharmaceutical care" and "Repeat prescribing" |
| 9.45am: New medicines: what, when and how?
Speakers: Dr Jonathan Shapiro (senior fellow, Health Services Management Centre, University of Birmingham), Ms Mercy Jeyasingham (chief executive, Association for All Speech Impaired Children, and patient representative on the partners' council of National Institute for Clinical Excellence) and Mr Brian Stoten (chairman, Warwickshire health authority) |
2.30pm: Hospital pharmacy session - Vision of the future: the development of hospital pharmacy
Speakers: Dr Norman Lannigan (director of pharmacy, Lothian University Hospital NHS trust) and an NHS trust senior manager |
| 10.30am: Microbiology sessions - The global threat of antibiotic resistance: novel approaches to find new antibiotic targets (in conjunction with the British Society for Antimicrobial Chemotherapy)
"Introductory overview" by Professor T. H. Pennington (department of medical microbiology, University of Aberdeen); "Evolution of antibiotic resistance" by Professor Brian Spratt (Wellcome Trust Centre for the Epidemiology of Infectious Disease, University of Oxford); "Genomics and transcriptomics in the search for new antibacterial targets " by Dr Martin Burnham (Smithkline Beecham, United States); and "Targeting resistance mechanisms" by Professor Keith Poole (department of microbiology and immunology, Queen's University, Kingston, Ontario, Canada) |
2.30pm: Industrial pharmacy session - Out-sourcing
"Manufacturing and packaging" by Ms Patricia Liston (Galpharm International Ltd); and "Contract analysis" by Mrs Sue Richardson (managing director and vice-president, Herd Mundy Richardson) |
| 10.30am: Pharmaceutical analysis - Lab on a chip (in conjunction with the Joint Pharmaceutical Analysis Group)
"The case for, and future of, miniaturisation" by Dr Derek Craston (Laboratory of the Government Chemist); "Single cell assays in lab-on-a-chip formats" by Professor Jon Cooper (University of Glasgow); "A walk through the pharmaceutical laboratory on a chip" by Dr Coulton Legge (Glaxo Wellcome); "Microchip-based synthesis and total analysis systems (µSYNTAS) for the on-line production of compound libraries" by Dr Michael Mitchell (Imperial college, University of London); and "Chip on a lab: a new approach to diagnostic testing" by Mr James Jackson (Smart Sensor Telemed Ltd) |
3pm: Microbiology session (in conjunction with the British Society for Antimicrobial Chemotherapy)
"Targeting virulence as a means of attenuating infection" by Professor Paul Williams (University of Nottingham); "Recent approaches for the discovery of bacterial genes essential for growth in vivo" by Dr Christopher Tang (John Radcliffe hospital, University of Oxford); "Mixing and matching; a biotech approach to building new antibiotics" by Professor J. Staunton (department of chemistry, University of Cambridge) |
| 10.30am: Drug delivery session - Barriers to drug delivery (joint session with United Kingdom-Ireland Controlled Release Society )
"The biochemical barrier to gastrointestinal drug delivery" by Professor Les Benet (University of California, United States); "Drug delivery to the deep tissues of the eye" by Professor Vince Lee (University of Southern California, United States); "Blood-brain barrier" by Professor David Begley, University of London); "Pluronics to overcome p-glycoprotein in the blood brain barrier" by Professor Sasha Kabanov (University of Nebraska, United States); and "Overcoming p-glycoprotein in the gastrointestinal tract using polymeric excipients to produce orally active doxirubicin" by Professor Ruth Duncan (University of London) |
3pm: Short papers in pharmaceutical analysis |
| 10.30am: Drug discovery - Advances in the chemistry of anticancer drug development
"Telomere maintenance mechanism as a target for drug action" by Professor Laurence Hurley (Arizona Cancer Centre, United States); "The chemistry of novel antitumour antibiotics" by Professor Sid Hecht (University of Virginia, United States); "Crystal structure-based design of inhibitors of cyclin-dependent kinases (CDKs) and poly(ADP)ribose polymerase (PARP)" by Dr Roger Griffin (University of Newcastle) |
3pm: Emerging therapies in controlled release (in conjunction with the United Kingdom-Ireland Controlled Release Society)
"Recent advances in vaccine delivery systems" by Dr Derek O'Hagan (Chiron Corporation); "Advancing pulmonary delivery for new therapies" by Dr Stephen Farr (Aradigm Corporation); "Gene therapy and the delivery of DNA: a pharmaceutical challenge" by Dr Tony Phillips (Glaxo Wellcome); "Controlled delivery systems in tissue engineering" by Dr Mark Salzman (Cornell university, United States); and "Current and future developments in nasal delivery" by Professor Lisbeth Illum (West Pharmaceutical Services Drug Delivery & Clinical Research Ltd, Nottingham) |
| 11.45am: Joint community and hospital pharmacy session - The pharmacist's role in delivering clinical governance
Speakers: Ms Anne-Toni Rodgers (communications director, National Institute for Clinical Excellence); and Mr David Pruce (audit fellow, Royal Pharmaceutical Society) |
3pm: Advances in the chemistry of anticancer drug development
"Novel mechanisms for anticancer drug development" by Dr Randall Johnson (Smithkline, United States); "Chemistry of steroid sulfatase inhibition" by Professor Barry Potter (University of Bath) and "Inhibitors of signalling through the erbB family of transmembrane receptors: a major new class of anticancer drugs" by Professor Bill Denny (University of Auckland, New Zealand). |
| 11.45: Pharmacy practice research - Oral communications
Topic: "Pharmaceutical public health" |
4pm: Community pharmacy session - Pharmacists improving access to care
"NHS Direct" by Mrs Beth Taylor (pharmacy manager, Community Health South London NHS trust); "Walk-in centres" by a speaker from the walk-in centre in Birmingham; and "Booking systems: the Bologna experience" by John Schaechter (director of social policy, PMA Partnerships Ltd) |
| 11.45am: Industrial pharmacy session - The electronic medicines compendium
Speaker: Mr Steve Mott (general manager, Datapharm Communications Ltd, Association of the British Pharmaceutical Industry) |
4pm: Hospital pharmacy session - Pharmacists and controls assurance
Speaker: Keith Ridge (principal pharmacist, Office of the Chief Pharmacist) |
| 1pm: Lunchtime session: National initiative on drug delivery
"Introduction: The progress of the national initiative" by Professor Tony Moffat (chief scientist, Royal Pharmaceutical Society); "Key issues and the drug delivery map" by Professor Ruth Duncan (University of London); "The way forward" by Dr Keith Horspool (Pfizer Inc, Connecticut, United States); and "Funding of drug delivery by the research councils" by Dr Beverley Parsons (Biotechnology and Biological Sciences Research Council |
4pm: Industrial pharmacy session - Patient packaging: the challenges
"The industry's viewpoint" by Mr Martin Anderson (Association of the British Pharmaceutical Industry); "The patient's viewpoint" by Mr David Dickinson (consultant in health care communication); "A community viewpoint" by Mr Rob Darracott (E. Moss Ltd) |
| 2pm: Conference science medal lecture
"Biomaterials, biomimesis and biocompatibility" by Dr Andrew Lloyd (University of Brighton) |
5pm: Science poster sessions |
| 5pm: Practice research poster sessions | |
| 5pm: Primary Care Pharmacists Association session - Risk assessment for coronary heart disease |
| 9am: President's address
Mrs Christine Glover (President, Royal Pharmaceutical Society) |
2.30pm: Community pharmacy session - Pharmacists and service frameworks: developing guidelines and standards (1)
Launch of Royal Pharmaceutical Society practice guidance on asthma and chronic obstructive pulmonary disease: "Why the guidance has been produced" by Mr Hemant Patel (member of the Society's Council and chairman of its task force on asthma and COPD), followed by case studies presented by task force members demonstrating how the guidance can be used to improve practice |
| 9.30am: Ministerial address
"The Government's agenda" by Lord Hunt of Kings Heath (Parliamentary Under-Secretary of State for Health) |
2.30pm: Hot topics session (1)
Topics: "Cloning", "Use of generics", "On-line pharmacy", "Sexual health strategy", "Herbal medicines licensing" and "Expert patient groups" |
| 10am: Developing and delivering standards and guidelines
Dr Sheila Adam (health services director, NHS Executive); and Mr Bill Scott (chief pharmaceutical officer, Scotland) |
2.30pm: History of pharmacy session (organised by the British Society for the History of Pharmacy) "The history of the Order of St John from the crusades to the present day" by Dr A. Llewellyn Lloyd and "January 15, 1913: the day pharmacy in Britain entered a new era" by Dr John Hunt |
| 10.30am: Biopharmaceutics session
"Classifying the oral biopharmaceutical properties of drugs" by Professor Bill Charman (Monash university, Victoria, Australia); and "Formulation influences on drug absorption" by Professor Ron Borchardt (University of Kansas, United States) |
3pm: Biopharmaceutical session
"In silico, in vitro and in vivo approaches to absorption in drug delivery" by Dr John Ayrton (Glaxo Wellcome); "Dissolution behaviour and prediction of oral absorption" by Professor Jennifer B. Dressman (Johann Wolfgang Goethe University Institute for Pharmaceutical Technology, Frankfurt, Germany) |
| 10.30am: Drug delivery session - Innovative delivery systems: pre-market developments (in conjunction with the United Kingdom-Ireland Controlled Release Society)
"The evolution of poly(orthoesters): a 30-year historical perspective" by Dr Jorge Heller (Advanced Polymer Systems); "Molecular design of muco-adhesive drug delivery systems" by Professor Nicholas Peppas (Purdue university, Indiana, United States); "Stimuli-sensitive systems" by Professor Pat Stayton (University of Washington, United States); "Iontophoresis" by Professor Richard Guy (University of Geneva, Switzerland) and "Novel soluble polymers" by Dr Steve Brocchini (University of London) |
3pm: Drug delivery session - Innovative delivery systems: at market (in conjunction with the United Kingdom-Ireland Controlled Release Society)
"Powder injection: novel mode of drug delivery for wide-ranging applications" by Dr Pascal Hickey (Powderject Pharmaceuticals); "Sulfobutylether cyclodextrin" by Dr Diane Thompson (Cydex); address by Professor Sandra Downes (Smith & Nephew); "The intravaginal ring drug delivery system" by Professor David Woolfson (Queens University, Belfast) and "A new age in inhalable medicines" by Dr John S. Patton (Inhale Therapeutics) |
| 10.30am: Pharmaceutical analysis session - Recent advances in particle characterisation (in conjunction with the Joint Pharmaceutical Analysis Group)
"High speed particle imaging" by Dr J. Boaler (Oxford Instruments); "Characterisation techniques in gene delivery" by Dr S. Stolnik (University of Nottingham); "High concentration particle sizing using acoustic attenuation spectroscopy" by Dr Paul Kippax (Malvern Instruments); "Quality assurance and audit in particle characterisation" by Dr J. Sherwood (Astra Zeneca, Macclesfield); and "Characterisation of aggregating systems) by Dr Clive Washington (University of Nottingham) |
3pm: Short papers in pharmaceutical analysis |
| 10.30am: Materials science sessions - Nanotechnology in the pharmaceutical sciences "Self-assembly delivery systems" by Professor Sandy Florence (University of London); "Nanoengineering of drug crystals) by Dr Gary Liversidge (Nanosystems, United States); "Nanoengineering of bioactive polymer scaffolds for tissue engineering" by Dr Kevin Shakesheff (University of Nottingham); "Crystals and cures: pharmaceuticals from a diffraction viewpoint" by Dr Kenneth Shankland (Rutherford Laboratory); and "Measuring nanoproperties of pharmaceuticals" by Dr Clive Roberts (University of Nottingham) | 3pm: Materials science sessions - New techniques for the characterisation of dosage forms
"The current and potential uses of process tomography as a means of studying pharmaceutical systems" by Professor Richard Williams (University of Leeds); "Improving solid dosage form design using Raman and near infrared microscopy" by Dr Don Clark (Pfizer Ltd); "Recent advances in microthermal analysis" by Professor Mike Reading (University of Loughborough); "Thermally stimulated current as a novel means of characterising pharmaceuticals" by Professor Colette Lacabanne (University of Toulouse, France); "Time-of-flight secondary ion mass spectrometry (ToF-SIMS) for chemical imaging of pharmaceutical dosage forms" by Dr Anna Belu (Physical Electronics) |
| 10.30am: Industrial Pharmacists Group and Academy of Pharmaceutical Sciences joint session - Intellectual property transfer from academia to industry
Topics: "Start-up company view", "Venture capitalist's view" and "Industrial perspective" |
4pm: Community pharmacy session - Pharmacists and service frameworks: developing guidelines and standards (2)
Launch of the Royal Pharmaceutical Society's practice guidance on mental health: Discussion with the Society's mental health task force on how pharmacists can relate the guidance to their own practice |
| 11.30am: Pharmacy practice research - Poster discussion forum
Topics to include: "Improving prescribing in homes for the elderly" and "Continuing education and professional development" |
4pm: Hot topics session (2) Topics: "Genetically modified products", "Pharmacists in primary care trusts", "Wastage of medicines", "Over-the-counter medicines" and "Teaching fit for purpose" |
| 11.30am: Community pharmacy session - Pharmacists and service frameworks: developing guidance and standards
"Coronary heart disease" by Dr Roger Boyle (National CHD Director); and "Cancer" by Professor Mike Richards (National Cancer Director) |
5pm: Science poster sessions |
| 1.15pm: Academy of Pharmaceutical Sciences - Annual general meeting | 5pm: Practice research poster sessions |
| 2pm: Astra Zeneca industrial achievement award lecture
"The pharmaceutical industry and the evolution of molecular medicine" by Dr George Poste (Health Technology Networks) |
5pm: Primary Care Pharmacists Association - Coronary heart disease registers: how can pharmacists become involved? |
| 2.30pm: Pharmacy practice research oral communications - Influencing prescribing |
| 9am: Keynote address
"The impact of the genomic revolution on medicine" by Professor Ray Baker (chief executive, Biotechnology and Biological Sciences Research Council) |
Noon: Conference lecture
"Should doctors be Darwinian?" by Professor Richard Dawkins (Charles Simonyi professor of the public understanding of science, University of Oxford) |
| 9.30am: The great debate - Putting our house in order: professional performance and self-regulation
Speakers: Miss Ann Lewis (Secretary and Registrar, Royal Pharmaceutical Society), Dr Finlay Scott (chief executive, General Medical Council) and Ms Donna Covey (chief executive, Association of Community Health Councils in England and Wales) |
2.15pm: Pharmacy Law and Ethics Association - Closing ranks or protecting the public? Ensuring that self-regulation takes care of the consumer
Topics to include: "An overview of self-regulation in health care", "The impact of the Health Act 1999" and "How pharmacy practice must respond" and a panel discussion |
| 10am: Impact of the genomic revolution on medicine
"Current and future prospects in stem cell research for organ regeneration" by Dr Robert Lanza (Advanced Cell Technology, United States); "Medical genetics" by Professor Anthony P. Monaco (Wellcome Trust Centre for Human Genetics); and address by Professor John Clark (Roslin Institute, Midlothian) |
3pm: Genetic factors in drug therapy
"Pharmacogenetics in cancer chemotherapy or pharmacogenomics in action" by Professor William Evans (University of Tennessee); and "Genetics in health care" by Professor Klaus Lindpaintner (head of genetics, Hoffman La Roche, Basel, Switzerland) |
| 10am: Materials science session - New materials and processes
"Toxicology is the mother of invention: reinventing drug delivery for the 21st century" by Professor John Staniforth (University of Bath); "Polymers, biomaterials and supercritical fluids" by Dr Steven Howdle (University of Nottingham); "From desktop publishing to drug delivery: pharmaceutical applications for electrostatic powder deposition" by Dr Marshall Whiteman (Phoqus); and "Streamlining technology transfer and scale-up: putting theory into practice" by Dr Mike Valazza (IPC, Kentucky) |
3pm: Contributed papers session - Materials science |
| 10am: Pharmacognosy session
"EC for some" by Professor Jack Woolley (De Montfort university, Leicester); and "Ethnobotany and ethnopharmacology: their role in future medicinal plant research" by Professor Michael Heinrich (School of Pharmacy, University of London) |
3.45pm: Genetics - friend or foe?
"Crop improvements through genetic modification: the science, the politics and real issues" by Professor Don Grierson (University of Nottingham) and "Beyond the scientific dimension of genetic modification" by Dr Douglas Parr (chief scientific adviser, Greenpeace) |
| 10am: Genetic factors in drug therapy
"Historical perspective" by Professor David Price Evans (Riyadh armed forces hospital, Saudi Arabia); "P450 enzymes and polymorphism" by Professor Geoff Tucker (University of Sheffield); and "Polymorphisms of drug receptors" by Dr Ian Hall (University of Nottingham) |
|
| 11am: Complementary medicine
Topics: "Complementary medicine: is there convincing evidence?", "Integrating complementary medicine into the NHS" and "Complementary medicine and pharmacy practice" |